Serious Adverse Effect of Benzbromarone Re-Emphasized

The Korea Food and Drug Administration (KFDA) recently released an advisory letter addressed to the healthcare professionals on the reported mortality instances in Japan by medications containing benzbromarone, which is used for treatment of hyperuricemia (abnormally elevated blood level of uric acid) of gout.

While the precautions on the adverse hepatic effects leading to a possible mortali...